Zobrazeno 1 - 6
of 6
pro vyhledávání: '"April Jorge"'
Autor:
April Jorge, Yuqing Zhang, Kristin M. D’Silva, Zachary S. Wallace, Andrew Cohen, Natalie McCormick, Hyon K. Choi
Publikováno v:
Arthritis & Rheumatology
Arthritis Rheumatol
Arthritis Rheumatol
Patients with systemic autoimmune rheumatic diseases (ARDs) continue to be concerned about risks of severe coronavirus disease 2019 (COVID-19) outcomes. This study was undertaken to evaluate the risks of severe outcomes in COVID-19 patients with syst
Autor:
Yuqing Zhang, Kristin M. D’Silva, Natalie McCormick, Zachary S. Wallace, Hyon K. Choi, April Jorge, Andrew Cohen
Publikováno v:
The Lancet Rheumatology
Summary Background As the COVID-19 pandemic continues worldwide, severe COVID-19 outcomes remain a major concern for patients with rheumatic and musculoskeletal diseases. We aimed to investigate temporal trends in COVID-19 outcomes in patients with r
Publikováno v:
Arthritis & Rheumatology. 71:403-410
OBJECTIVE A prior study showed that premature mortality among patients with end-stage renal disease (ESRD) due to lupus nephritis (LN) persisted in the US between 1995 and 2006. The present study was undertaken to extend this analysis through 2014 to
Publikováno v:
The Journal of Rheumatology. 45:1689-1695
Objective.Systemic autoimmune rheumatic diseases (SARD) are associated with an increased risk of premature cardiovascular disease (CVD) and all-cause mortality. We examined the potential survival benefit of statin use among patients with SARD in a ge
Autor:
Emma Stevens, April Jorge, Hongshu Guan, Kazuki Yoshida, Candace H. Feldman, Brendan M. Everett, Karen H. Costenbader, Daniel Li, Cameron B. Speyer
Publikováno v:
Rheumatol Int
OBJECTIVE: Systemic lupus erythematosus (SLE) severity, reflecting both disease intensity and duration, is heterogeneous making it challenging to study in administrative databases where severity may confound or mediate associations with outcomes. Gar
Publikováno v:
Annals of the Rheumatic Diseases. 75:550.3-551
Background Many studies have found that patients with SLE have a substantially increased risk of cardiovascular complications. However, the magnitude of the risk for venous thromboembolism (VTE) has not been well quantified in this patient group, par